首页> 外文期刊>Analytical methods >Non-invasive prenatal detection of trisomy 21 by quantifying segmental duplication in maternal plasma with digital PCR
【24h】

Non-invasive prenatal detection of trisomy 21 by quantifying segmental duplication in maternal plasma with digital PCR

机译:通过数字PCR定量分析母体血浆中的节段重复,进行21三体性的无创产前检测

获取原文
获取原文并翻译 | 示例
           

摘要

Non-invasive detection of trisomy 21 is a safe and effective way for prenatal diagnosis. Although using next generation sequencing technology can achieve non-invasive detection of chromosomal abnormalities, a more convenient and cost-effective method is preferable for routine clinical applications. Here, we proposed a novel method for the detection of trisomy 21 by accurately quantifying the slightly increased amount of chromosome 21 in cell-free DNA from maternal plasma using digital PCR. The segmental duplication fragments on chromosome 21 and chromosome 1 were employed as the detection target of digital PCR. As low as 10% cell-free fetal DNA of trisomy 21 fetus in maternal cell-free DNA was successfully detected. Three trisomy 21 samples were unambiguously picked up from 15 clinical samples, indicating that our method has the potential for non-invasive diagnosis of trisomy 21.
机译:21号三体症的无创检测是一种安全有效的产前诊断方法。尽管使用下一代测序技术可以实现对染色体异常的无创检测,但对于常规临床应用而言,更方便且更具成本效益的方法是首选。在这里,我们提出了一种新的检测三体性21的方法,该方法通过使用数字PCR准确定量来自母体血浆的无细胞DNA中21号染色体的稍微增加的量。将21号染色体和1号染色体上的节段重复片段用作数字PCR的检测目标。成功检测出母体无细胞DNA中低至21%的三体性胎儿的10%无细胞胎儿DNA。从15个临床样本中明确地采集了3个21三体样本,这表明我们的方法具有无创诊断21三体的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号